Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
QIMA
Poitiers, France
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
QIMA Life Sciences provides non-GLP preclinical, translational, and early clinical research support, including AI-driven in silico assessment, in vitro, ex vivo, and in vivo evaluations for drug and cosmetic development, with a strong record of supporting clinical translation and alternative-to-animal-testing approaches[1][2][3][7].
- Therapeutic areas
- ImmunologyOphthalmologyEndocrinologyRheumatologyGastroenterologyNeurologyOtherDermatologyOncology
- Modalities
- Small moleculePeptidesProteinBiologicAntibodyAntibody-drug conjugateMedical deviceFormulation (topical, oral, etc.)Synthetic moleculeNatural extracts (plant, marine, bacterial)Biosimilar
- Industry
- Contract Research Organization
Beyond the preview
Go deeper on QIMA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QIMA.